Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.52 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.52 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.44 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.44 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.44 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.44 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.44 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.44 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.44 |
| ▸ | PIK3C3 | Q8NEB9 | 5/20 | 0.43 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.42 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6962021 | 0.98 | CHRNB2 (0.50) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Hydrochloric Acid SCHEMBL28604180 | 0.96 | CHRNB2 (0.49) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL5530018 | 0.94 | CHRNB2 (0.58) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL3011993 | 0.94 | CHRNB2 (0.58) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL28866229 | 0.92 | CHRNB2 (0.56) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Methyl Alcohol SCHEMBL23748591 | 0.89 | CHRNB2 (0.58) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL4017959 | 0.88 | EGFR (0.46) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL4552972 | 0.86 | CHRNA7 (0.47) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| Alcohol SCHEMBL8570760 | 0.84 | CHRNB2 (0.53) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL22165467 | 0.82 | CHRNB2 (0.50) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539578-A | Physical crosslinking type polymer anion exchange membrane and preparation method thereof | 北京化工大学 | 2022-05-27 | — | — | CN | claimed |
| CN-114524912-A | Side-chain piperidine cation grafted polybiphenyl alkaline membrane and preparation method thereof | 北京化工大学 | 2022-05-24 | — | — | CN | claimed |
| US-20220024879-A1 | COMPOUNDS FOR TREATMENT OF HEPACI VIRUS INFECTION AND METHOD FOR DETERMINING THERAPY OF HEPACI VIRUS INFECTION, IN PARTICULAR, HCV INFECTION | TWINCORE ZENTRUM FUR EXPERIMENTELLE UND KLINISCHE INFEKTIONSFORSCHUNG GMBH (DE) | 2022-01-27 | — | — | US | claimed |
| EP-3898593-A2 | COMPOUNDS FOR TREATMENT OF HEPACI VIRUS INFECTION AND METHOD FOR DETERMINING THERAPY OF HEPACI VIRUS INFECTION, IN PARTICULAR, HCV INFECTION | Gottfried Wilhelm Leibniz Universität Hannover (DE) | 2021-10-27 | — | — | EP | claimed |
| CN-109411788-B | Aza spiro cation loaded polybiphenyl basic film and preparation method thereof | 北京化工大学 | 2021-07-13 | — | — | CN | claimed |
| CN-111740118-A | Hydrophobicity regulation and control method for catalyst layer of alkaline polyelectrolyte fuel cell | 武汉大学 | 2020-10-02 | — | — | CN | claimed |
| WO-2020127211-A2 | COMPOUNDS FOR TREATMENT OF HEPACI VIRUS INFECTION AND METHOD FOR DETERMINING THERAPY OF HEPACI VIRUS INFECTION, IN PARTICULAR, HCV INFECTION | GOTTFRIED WILHELM LEIBNIZ UNIVERSITÄT HANNOVER (DE) | 2020-06-25 | — | — | WO | claimed |
| EP-3670498-A1 | COMPOUNDS FOR TREATMENT OF HEPACI VIRUS INFECTION AND METHOD FOR DETERMINING THERAPY OF HEPACI VIRUS INFECTION, IN PARTICULAR, HCV INFECTION | Gottfried Wilhelm Leibniz Universität Hannover (DE) | 2020-06-24 | — | — | EP | claimed |
| CN-109306151-A | One kind is without ether oxygen bond type polymer anion-exchange membrane and preparation method thereof | 大连理工大学 | 2019-02-05 | — | — | CN | claimed |
| CN-105854775-B | A kind of manganese slag lightweight ceramic tile additive special production apparatus and method of work and its preparation method of critical component | 徐州工程学院 | 2017-08-25 | — | — | CN | claimed |
| CN-1132625-A | NK-1 receptor antagonits and 5HT3 receptor antagonists for treatment of emesis | PFIZER (US) | 1996-10-09 | — | — | CN | claimed |
| CN-1132072-A | NK-1 receptor antagonists for the treatment of nerve injury and stroke | PFIZER (US) | 1996-10-02 | — | — | CN | claimed |
| CN-1121806-A | Pharmaceutical agents for treatment of emesis | PFIZER (US) | 1996-05-08 | — | — | CN | claimed |
| EP-0296316-B1 | 1,4-DIHYDROPYRIDINE ENANTIOMERS | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1993-09-01 | — | — | EP | claimed |
| US-4994461-A | Vasodilators; treating cardiovascular disorders | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1991-02-19 | — | — | US | claimed |
| EP-0221376-B1 | N-SUBSTITUTED DIPHENYL PIPERIDINES | F. HOFFMANN-LA ROCHE AG (CH) | 1990-06-20 | — | — | EP | claimed |
| EP-0343193-A1 | 1,4-DIHYDROPYRIDINE ENANTIOMERS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1989-11-29 | — | — | EP | claimed |
| EP-0296316-A1 | 1,4-Dihydropyridine enantiomers | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1988-12-28 | — | — | EP | claimed |
| WO-1988007525-A1 | 1,4-DIHYDROPYRIDINE ENANTIOMERS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1988-10-06 | — | — | WO | claimed |
| EP-0221376-A2 | N-substituted diphenyl piperidines | F. HOFFMANN-LA ROCHE AG (CH) | 1987-05-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220024879-A1 | COMPOUNDS FOR TREATMENT OF HEPACI VIRUS INFECTION AND METHOD FOR DETERMINING THERAPY OF HEPACI VIRUS INFECTION, IN PARTICULAR, HCV INFECTION | HAVCR2, HCCS, HELZ | CHRNB2 4037/4885CHRNB4 4270/4885CHRNA3 2371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.